Molindone: Clinical Trials

4 trials of Molindone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 2 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 41Completed 1

Follow Molindone: new trials by email Literature Review of Molindone trials Research Report on Molindone

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care: - Adenovirus, Anesthesia
CompletedDaniel Benjamin35202011-11-012023-09-06
Open-Label, Extension Study to 810P202
Molindone - Impulsive Aggression Comorbid With ADHD in Children
Phase 2CompletedSupernus Pharmaceuticals, Inc.782011-09-012017-05-02
Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems
SPN-810 - Attention Deficit Disorder With Hyperactivity, Conduct Disorder
Phase 2CompletedSupernus Pharmaceuticals, Inc.782008-10-212025-12-09
Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS)
Risperidone, Olanzapine (enrollment closed in this treatment), Molindone - Schizophrenia
Phase 4CompletedUniversity of North Carolina, Chapel Hill1162002-02-012014-03-26

Conditions studied

Schizophrenia (2)  ·  Adenoviridae Infections (1)  ·  Anxiety Disorders (1)  ·  Arrhythmias, Cardiac (1)  ·  Attention Deficit Disorder with Hyperactivity (1)  ·  Autistic Disorder (1)  ·  Bipolar Disorder (1)  ·  Bradycardia (1)  ·  Central Nervous System Infections (1)  ·  Conduct Disorder (1)  ·  Cytomegalovirus Retinitis (1)  ·  Endocarditis (1)  ·  Epilepsy (1)  ·  Headache (1)  ·  Healthcare-Associated Pneumonia (1)

Sponsors

Supernus Pharmaceuticals, Inc. (2)  ·  Daniel Benjamin (1)  ·  University of North Carolina, Chapel Hill (1)

Countries

United States (4)  ·  Canada (1)  ·  Israel (1)  ·  Singapore (1)  ·  United Kingdom (1)

Top investigators

Chi Hornik, PharmD (1)  ·  Linmarie Sikich, M.D. (1)  ·  Robert Findling, MD (1)

Results publications

PMID 17667476, PMID 17667477, PMID 18794207, PMID 20494268, PMID 22372512, PMID 22525956, PMID 24614374, PMID 24949994, PMID 26039810, PMID 26926644, PMID 27522443, PMID 28137820, PMID 28290120, PMID 28595147, PMID 28779462, PMID 29084742, PMID 29271816, PMID 29435949, PMID 29677389, PMID 29920116, PMID 30790601, PMID 31317556, PMID 31548185, PMID 31814149, PMID 32324313, PMID 32497307, PMID 32633541, PMID 33029806, PMID 33903114, PMID 34302290, PMID 35370711, PMID 35491971, PMID 41247430

NIH funding

U01MH061355 (1), U01MH061464 (1), U01MH062726 (1)